
Wosulin-N 40IU/ml Suspension for Injection
Marketer
Wockhardt Ltd
Salt Composition
Insulin Isophane (40IU)
Overview Wosulin-N 40IU/ml Suspension for Injection
InsuLin-N 40 IU/mL injectable suspension manages blood glucose in adults and children with type 1 or type 2 diabetes. This intermediate-acting insulin lowers blood sugar, mitigating the risk of diabetic complications. InsuLin-N 40 IU/mL is frequently used alongside rapid-acting insulin or oral hypoglycemics. Your healthcare provider will instruct you on subcutaneous injection technique. Discontinue use only under medical supervision. This medication is part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your physician. Regular blood glucose monitoring, including record-keeping and sharing results with your doctor, is crucial for dose optimization. Hypoglycemia is the most common adverse effect. Precise dosing, consistent meals, and diligent blood glucose monitoring help prevent this. Excessive alcohol consumption may also induce hypoglycemia. Injection site reactions (redness, swelling) may occur. Repetitive injections at the same site can cause lipodystrophy. Weight gain and edema are potential side effects. Avoid use if hypoglycemic. Consult your doctor prior to treatment if you have kidney, liver, or heart conditions, or if you are pregnant or breastfeeding, as dosage adjustments may be necessary.
Uses of Wosulin-N 40IU/ml Suspension for Injection
High blood sugar condition
Major Benefits of Wosulin-N 40IU/ml Suspension for Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Wosulin-N 40IU/ml Suspension for Injection:
- Hypoglycemia (low blood glucose level)
How to use Wosulin-N 40IU/ml Suspension for Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Wosulin-N 40IU/ml Suspension for Injection works:
NPH insulin 40IU/ml injectable suspension is an intermediate-acting formulation with an onset of action within one to two hours post-injection. Its mechanism mimics endogenous insulin, promoting glucose uptake by muscle and adipose tissue while concurrently inhibiting hepatic glucose production. This action contributes to glycemic control in individuals with diabetes mellitus.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Wosulin-N 40IU/ml injectable suspension is contraindicated.
PregnancySAFE IF PRESCRIBED
Injectable Wosulin-N 40 IU/mL suspension is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, clinical data from human pregnancies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Wosulin-N 40 IU/ml injectable suspension presents minimal risk to breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent threat to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Wosulin-N 40 IU/ml injectable suspension cautiously. Dosage modification of Wosulin-N 40 IU/ml injectable suspension may be necessary. Physician consultation is advised. Regular blood glucose monitoring is recommended to guide dosage adjustments.
LiverCAUTION
Patients with hepatic impairment should use Wosulin-N 40 IU/mL injectable suspension cautiously, potentially requiring dose modification. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dose adjustments.
What if you forget to take Wosulin-N 40IU/ml Suspension for Injection :
NA
Facts to Know About Wosulin-N 40IU/ml Suspension for Injection
| Label | Value |
|---|---|
| Chemical Category | Modified insulin |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Intermediate-acting human insulin |
